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AbstrACt
Objectives To demonstrate how data- driven variability 
methods can be used to identify changes in disease 
recording in two English electronic health records 
databases between 2001 and 2015.
Design Repeated cross- sectional analysis that applied 
data- driven temporal variability methods to assess month- 
by- month changes in routinely collected medical data. A 
measure of difference between months was calculated 
based on joint distributions of age, gender, socioeconomic 
status and recorded cardiovascular diseases. Distances 
between months were used to identify temporal trends in 
data recording.
setting 400 English primary care practices from the 
Clinical Practice Research Datalink (CPRD GOLD) and 451 
hospital providers from the Hospital Episode Statistics 
(HES).
Main outcomes The proportion of patients (CPRD 
GOLD) and hospital admissions (HES) with a recorded 
cardiovascular disease (CPRD GOLD: coronary heart 
disease, heart failure, peripheral arterial disease, stroke; 
HES: International Classification of Disease codes I20- I69/
G45).
results Both databases showed gradual changes in 
cardiovascular disease recording between 2001 and 
2008. The recorded prevalence of included cardiovascular 
diseases in CPRD GOLD increased by 47%–62%, which 
partially reversed after 2008. For hospital records in HES, 
there was a relative decrease in angina pectoris (−34.4%) 
and unspecified stroke (−42.3%) over the same time 
period, with a concomitant increase in chronic coronary 
heart disease (+14.3%). Multiple abrupt changes in the 
use of myocardial infarction codes in hospital were found 
in March/April 2010, 2012 and 2014, possibly linked to 
updates of clinical coding guidelines.
Conclusions Identified temporal variability could be 
related to potentially non- medical causes such as updated 
coding guidelines. These artificial changes may introduce 
temporal correlation among diagnoses inferred from 
routine data, violating the assumptions of frequently 
used statistical methods. Temporal variability measures 
provide an objective and robust technique to identify, and 
subsequently account for, those changes in electronic 
health records studies without any prior knowledge of the 
data collection process.
IntrODuCtIOn
Routinely collected electronic health records 
(EHR) are increasingly used for clinical 
research.1 2 They often pool data from 
different healthcare sites over multiple years, 
providing a readily available and representa-
tive national sample of clinical practice. The 
validity of results from observational studies 
heavily depends on the quality of the data,3 
and researchers have become increasingly 
aware of the importance of adequate data 
quality for obtaining reliable and reproduc-
ible findings.4 5 Systematic approaches to 
ascertain data quality in health data repos-
itories have traditionally focused on the 
data quality dimensions of completeness, 
strengths and limitations of this study
 ► We are able to show previously unreported chang-
es in coding of cardiovascular disease in two of the 
largest electronic health record databases in the UK.
 ► Temporal variability methods supports the semi-
automatic identification of time trends in data re-
cording within large and complex electronic health 
record databases.
 ► The methods can be applied to multitype and multi-
modal data, are robust to large sample sizes and can 
be performed simultaneously for multiple variables.
 ► Used metrics do not assess the correctness of codes 
entered by general practitioners, which require other 
validation techniques, but are able to signal the need 
for further validation.
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correctness and concordance.6 For example, validation 
studies of English EHR databases commonly focused 
on whether all relevant information on the patient is 
recorded (completeness), to which degree the recorded 
information reflects reality (correctness) and whether 
the recorded information agrees with information in a 
reference dataset (concordance).7 While answering these 
questions is of vital importance, they are not the only 
potential sources of bias.
Other factors that influence the reuse of data are less 
obvious and have often been neglected despite their 
potentially large impact on study results. Changes in 
clinical procedures over time, differences in processes 
between healthcare sites and the introduction of new 
guidelines can all cause unwarranted variations in the 
way data items are recorded, leading to artificial trends, 
irregularities and breaks in the data distributions. We 
have previously argued that these types of data variability 
over time and between participating healthcare sites pose 
a considerable threat to the validity and reproducibility 
of EHR studies.8 Studies that ignore these variations are 
susceptible to obtain results of limited applicability. For 
example, financial incentives to improve diabetes care 
might exaggerate increases in recorded and reported type 
II diabetes.9 At worst, variability in how data is collected 
might even introduce spurious relationships, such as 
when the above mentioned improved coding of type II 
diabetes reduces the incidence of patients with wrongly 
classified type I diabetes.10
In this study, we set out to demonstrate how data- driven 
methods can be used to identify irregularities in coding 
for clinical diagnoses over time using a recently devel-
oped, scalable approach that allows for easy comparison 
of similarities and differences in the distribution of demo-
graphic patient characteristics and cardiovascular diag-
nosis codes.8 11 Using this method, we show how changes 
in coding guidelines can and have affected cardiovascular 
disease recording in two major English EHR databases in 
primary care (Clinical Practice Research Datalink (CPRD 
GOLD)12) and secondary care (Hospital Episode Statis-
tics (HES)13) and discuss potential causes of detected 
variations in coding over time.
MethODs
Data sources
Clinical Practice Research Datalink (CPRD GOLD)
CPRD GOLD is a database of retrospective health records 
obtained directly from the practice management soft-
ware (Vision, InPractice Systems LTD) of 674 primary 
care practices across the UK.12 Recorded information 
includes patients’ demography, clinical symptoms, inves-
tigations, diagnoses, and tests entered by the clinician. 
All clinical information is coded using Read Codes, the 
clinical terminology used in UK primary care until April 
2018.14 As of 2015, CPRD GOLD collected data from 674 
practices, including data on 4.4 million actively contrib-
uting patients and 6.9 million historic patient records.12 
Primary care data used in this study was taken from the 
subset of 400 English practices that had existing linkage 
to census data. All data were obtained via the CALIBER 
research resource.15
Hospital Episode Statistics (HES)
HES Admitted Patient Care (APC) is a repository of 
hospital activity data collected as part of management, 
planning and reimbursement of NHS hospitals in 
England.13 Information is organised in finished consul-
tant episodes (ie, the time spent under the uninterrupted 
care of a single consultant) and includes patients’ demog-
raphy, admission and discharge dates, hospital diagnoses 
and performed procedures. Each episode has an assigned 
primary diagnosis, which denotes the main condition 
treated during that episode, and up to 19 secondary 
diagnoses that contain any comorbidities relevant to the 
episode. Diagnoses are coded using the International 
Classification of Diseases 10th revision (ICD-10) codes and 
surgical procedures are recorded using OPCS-4 codes. In 
the financial year 2014/15, a total of 18.7 million episodes 
from 451 NHS hospital providers were captured in HES, 
which was equal to 34.3 episodes per 100 person- years.13 
Data from HES used in this study was preaggregated by 
month, age group, gender, socioeconomic status and 
3- character ICD-10 code.
study design and population
Using the above datasets, we conducted two cross- 
sectional analyses of electronic health records from 
English primary care (CPRD GOLD) and secondary 
care (HES) between 2001 and 2015. The data from each 
database were divided into monthly cross- sectional slices 
(figure 1A).
For CPRD GOLD, patients contributed to any given 
month if they were between 20 and 110 years old at the 
beginning of the month and had been registered with their 
GP for at least 1 year. All patient data was ascertained on the 
first day of each month. Patients who left the practice during 
the month still contributed to that month. Data for each 
month included age (20–39, 40–59, 60–79, ≥80), gender, 
socioeconomic status (quintiles of the patient’s Index of 
Multiple Deprivation (IMD) 201516) and presence of coro-
nary heart disease (CHD), heart failure, peripheral arterial 
disease (PAD) and stroke. Patients were required to have a 
complete record on age, gender and socioeconomic status, 
excluding those that did not (<0.1% of patients). Patients 
and practices were further required to fulfil standard data 
quality checks as performed and reported by CPRD.12 The 
four cardiovascular conditions were ascertained separately 
and coded as present or absent. Presence of cardiovascular 
disease was defined as the presence of a relevant diagnosis 
code at any time before that month. Included diagnosis 
codes were directly taken from the Quality and Outcomes 
Framework (QOF; V.36.0), a financial incentive scheme 
introduced in 2004 aimed at improving the management 
and recording of chronic disease in primary care (see online 
supplementary table 1). An absence of a diagnosis code in 
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Figure 1 Step- by- step explanation to estimate and visualise the temporal variability of a dataset. Methods included in the R 
package EHRtemporalVariability were created to support researchers with all steps in this process.
a patient’s medical history was interpreted as absence of the 
disease.
For HES, all recorded diagnosis of ICD chapters I20- 
I69 (including CHD, heart failure, stroke, but not PAD; 
online supplementary table 2) and G45 (transient isch-
aemic attacks) associated with an admission of patients 
aged 40 years or more were counted by month and 
stratified by age (40–44, 45–49, 50–54, 55–59, 60–64, 
65–69, 70–74,≥75), gender and socioeconomic status 
(quintiles of the patient’s IMD 2015). The age range 
and classification differed from that used in CPRD due 
to differences in the availability of the data. We did not 
distinguish between primary and secondary diagnoses 
and included all codes recorded during an admission. 
A summary of the included data for each dataset can be 
found in online supplementary tables 3–6.
temporal variability metrics
Variation in coding across months in both datasets was 
assessed via temporal variability methods previously 
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Figure 2 IGT plot of demography (without age*) and 
cardiovascular disease prevalence in CPRD between 2001 
and 2015. Each point represents joint prevalence in a 
single month (labelled with the last 2 digits of the year and 
the month) and distances represent the relative difference 
between them. Dimensions have no inherent meaning but 
represent the three ordered dimensions of highest variability 
as determined by multidimensional scaling. (a) Between 
2001 and 2008, there was a gradual increase in disease 
prevalence, with two indentations corresponding to the 
years 2003 and 2005. (b) In 2008, the general trend reverses 
and prevalences decrease again, shown by a change in 
the direction of the graph. (c) The magnitude of variability 
increases after 2011, predominantly owing to changes in the 
socioeconomic status due to a reduction in the number of 
practices contributing to the dataset. Detailed subplots of a, 
b and c can be found in the supplementary material (online 
supplementary figure 1). CPRD GOLD, Clinical Practice 
Research Datalink; IGT, information- geometric temporal; J, 
January; F, February; M, March; A, April; m, May; j, June; x, 
July; a, August; S, September; O, October; N, November; 
D, December. *The given graph excluded the age variable 
for clarity. Since CPRD GOLD includes only the year of 
birth, including age leads to artificial yearly jumps in July 
when every patient is considered 1 year older. The overall 
conclusion remains unaltered. A full graph including age can 
be found in the supplementary material (online supplementary 
figure 2).
proposed and tested by two of the authors.8 17 These metrics 
compare changes in the frequency of a single trait (eg, 
heart failure) or the joint occurrence of multiple traits (eg, 
male and heart failure) within a patient population over 
time using the monthly joint distribution of all variables of 
interest. In the simplest case where all variables are cate-
gorical, the joint distribution is simply the histogram of all 
possible value combinations (figure 1A). Temporal vari-
ability quantifies the differences in those monthly distribu-
tions based on pairwise distances between them (figure 1B). 
For the purpose of this study, we used the Jensen- Shannon 
distance (JSD), an information theoretic measure that 
estimates the degree of similarity between two probability 
distributions,11 where 0 means equal distributions and 1 
means no- overlap on the distributions. Notably, all pairwise 
distances are bound and independent of sample size. The 
dissimilarity matrix resulting from all pairwise comparisons 
can be mapped into a Euclidean space using multidimen-
sional scaling (figure 1C18), yielding a plot that visualises the 
data’s evolution over time and allows a graphical analysis 
of data recording trajectories, that is, systematic patterns in 
the data’s evolution. A detailed description of the methods 
can be found in Sáez et al (2015)17 and Sáez et al (2016).8 
Functions to perform the temporal variability analysis 
were implemented in the R package EHRtemporalVariability 
(https:// github. com/ hms- dbmi/ EHRt empo ralV aria bility).
statistical analysis
Empirical probability distributions of both datasets 
were estimated for each month by calculating the joint 
histogram divided by the total number of observations 
in each month, that is, the proportions of observations 
with each possible combination of variables. For CPRD 
GOLD, this represents the prevalence of cardiovascular 
diseases at the beginning of each calendar month, strati-
fied by age group, gender and socioeconomic status. The 
denominator was the number of registered patients at the 
beginning of the month. For HES, proportions represent 
the relative frequency of included 3- character cardiovas-
cular ICD-10 codes (eg, I21 Acute Myocardial Infarction), 
again stratified by demography. The denominator was the 
total number of included cardiovascular codes recorded 
for a hospital admission in that month.
For each dataset, the temporal variability was calculated 
jointly for all covariates in a given month as described 
above. The estimated variability was plotted in a 3D scatter 
plot and visually inspected for data recording trajectories. 
Plots were searched for gradual trends, abrupt changes, 
seasonality, distinct subgroups and outliers.19 Where 
trends, breaks or discontinuities were observed, the same 
analysis was performed for each variable individually in 
order to isolate the source of the discovered deviation.
results
The variables extracted from CPRD GOLD showed a 
gradual trend from 1 month to the next between 2001 
and 2007 (figure 2 and online supplementary figures 1 
and 2), mostly driven by changes in prevalence of cardio-
vascular diseases. The pattern suggested a continuous 
evolution of disease prevalence compatible with social 
factors (eg, ageing) or incremental improvements in 
diagnostic coding or in clinical procedures. Smaller devi-
ations from this overall trend could be seen at the end 
of 2002 and throughout 2005. Across the 8 years, the 
data distribution of cardiovascular disease prevalence 
changed with an average magnitude of about 1.5×10–3JSD/
month, which can be roughly viewed as a ~0.15% difference 
between consecutive histograms of disease prevalence. 
For comparison, if we analysed only a single variable, a 
change in JSD/month of this size would be obtained if its 
prevalence rose from 1% to 2.2%. Note further that the 
estimated JSD depends on base prevalence and is larger 
for very small or very large prevalence. An absolutely 
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Figure 3 IGT plot of demography and cardiovascular 
disease coding in HES between 2001 and 2015. Each 
point represents joint prevalence in a single month (labelled 
with the last 2 digits of the year and the month) and 
distances represent the relative difference between them. 
Dimensions have no inherent meaning but represent the three 
dimensions of highest variability (in order) as determined 
by multidimensional scaling. (a) From 2001 to 2009, there 
was a gradual change in which cardiovascular codes were 
associated with hospital admission. The data distributions 
started to diverge from the previous trend in March 2009. 
(b) In March 2010, the distribution of cardiovascular codes 
abruptly changed. (c and d) Similar and even stronger 
changes in cardiovascular disease coding occurred again 
in April 2012 and April 2014. The distributions within these 
2 year batches remained stable. Detailed subplots of a, b, 
c and d can be found in the supplementary material (online 
supplementary figure 4). IGT, information- geometric temporal; 
J, January; F, February; M, March; A, April; m, May; j, June; x, 
July; a, August; S, September; O, October; N, November; D, 
December.
larger, but relatively smaller, rise in prevalence from 51% 
of patients to 57% would also give the same JSD/month. 
Changes across this period were mainly attributable to 
an increase in the number of patients with heart failure 
(from 6.7/1000 patients at the start of 2001 to 10.8/1000 
by the end of 2007; +62%), stroke (from 14.4/1000 to 
23.4/1000; +62%), PAD (from 7.0/1000 to 10.3/1000; 
+47%) and to a lesser extent CHD (from 44.7/1000 to 
48.2/1000; +7.8%).
From 2008 onwards, the trend shifted direction, owing 
to a reduction and partial reversal in the prevalence of 
heart failure, PAD and most notably CHD (from 49/1000 
at the beginning of 2008 to 39/1000 at the end of 2015; 
20% reduction). The estimated average magnitude 
of change increased to 2.4×10–3JSD/month between 2008 
and 2015. Starting in March 2011, the gradual pattern 
diverged from the relatively straight path seen before due 
to shifts in the socioeconomic distribution of the patient 
population. This coincided with a substantial drop of 
contributing practices from more than 343 practices in 
January 2011 to 165 active practices in December 2015 
(online supplementary figure 3).
The distribution of cardiovascular diagnoses associ-
ated with HES admissions experienced a gradual change 
similar to that observed for CPRD GOLD until the end of 
2008 (figure 3 and online supplementary figure 4). In this 
period, the use of codes generally stayed comparable and 
shifted only over the course of multiple years. Notable 
changes were seen for I20 Angina pectoris (−34.4%), 
I64 Unspecified stroke (−42.3%) and I25 Chronic CHD 
(+14.3%). After a transition period in 2009, distributions 
stopped to evolve gradually and started to cluster tightly 
by NHS financial year (April to March—figure 3). There 
was a major shift in cardiovascular admission coding 
every 2 years (financial years 2010/2011, 2012/2013 and 
2014/2015). The abrupt changes were primarily due to 
differences in the ICD-10 codes used, while age, gender 
and socioeconomic status remained largely stable.
In particular, chapters I20–I25 experienced noticeable 
temporal breaks (figure 4). While I21 Acute myocardial 
infarction declined in relative frequency starting in 2006, 
it increased from 8.0% of included codes in March 2012 
to 10.9% in April 2012 (+36%) and remained stable there-
after. Simultaneously, the related code I22 Subsequent 
myocardial infarction (including reinfarction and recur-
rent infarction) dropped from 1.4% in March to 0.5% in 
April (−64%) and finally to ~0.1% after September 2012. 
I20 Angina pectoris decreased from 18.8% in January 
2001 to 10.2% in March 2014 (−45.7%), after which 
it further declined by 2% points to 8.4% in April 2014 
(−17.6%).
DIsCussIOn
We discovered both gradual and abrupt changes in the 
distribution of cardiovascular patient populations in two 
large English EHR databases between 2001 and 2015 
using recently developed data quality measures (table 1). 
The observed differences in cardiovascular disease coding 
might bias clinical phenotypes when applied over the 
entire study period, introducing correlation within time 
periods that violate the assumptions underlying common 
statistical methods (eg, regression analysis). Temporal 
variability measures provided an objective and robust way 
to identify those changes without any prior knowledge of 
the data.
Many studies have used CPRD GOLD to look at 
the incidence,20–23 prevalence20 21 23 24 and outcomes 
of cardiovascular disease.25 26 However, none of these 
studies mentioned changes in the coding of diseases 
and only one of these studies reported findings per 
year.23 Changes in coding over time tend to be under- 
reported in research papers, their identification limited 
to dedicated validation studies, which depending on the 
disease investigated may or may not exist. To the best of 
our knowledge, no patterns in the recording of included 
cardiovascular diseases have been reported for CPRD 
GOLD yet. Previous validation studies in other chronic 
diseases did report changes in coding over time. Among 
others, improved coding has been reported for chronic 
obstructive pulmonary disease,27 diabetes,10 body mass 
index28 and smoking status.29 Improvements in primary 
care coding were primarily linked to the introduction of 
QOF in 2004, a payment scheme which incentivised better 
coding and management of chronic diseases. In line with 
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Figure 4 DTM of ICD-10 coding linked to hospital admissions in HES between 2001 and 2015. Each row represents a single 
ICD-10 code (3 characters) and the colour shows the proportion of admissions with that code in each month. Gradual changes 
in code frequency can notably be seen for I20—angina pectoris, I21—acute myocardial infarction, I63—cerebral infarction and 
I64—stroke, not specified. Abrupt changes appear in the coding of G45—transient Cerebral ischaemic attack (2009), I21—acute 
myocardial Infarction (2010 and 2012) and I20—angina pectoris (2014). DTM, data temporal map; HES, Hospital Episode 
Statistics; ICD-10, International Classification of Diseases 10th revision.
these studies, we found alterations of the overall trend 
leading up to QOF (December 2002–December 2003) 
and following its introduction (October 2004–September 
2005). However, these effects were small and the estimated 
prevalence had already been rising before 2003 and kept 
increasing after 2005. A study analysing the coding of 
diabetes further found a sharp increase of coded type 
2 diabetes in 2004 that slowly started to decrease again 
after 2008,9 around the same time that we observed a 
reversal of cardiovascular prevalence. It is unclear what 
prompted these changes and whether they might be 
related. Our method further detected notable changes in 
patient population after 2011, mainly due to changes in 
the distribution of socioeconomic status. This was likely 
related to a considerable reduction in the number of 
participating practices from around 350 to 165 at the end 
of the study period, potentially due to practices switching 
to new practice management software incompatible with 
CPRD GOLD.30
Data on cardiovascular admissions from HES have been 
used alone or linked with primary care data from CPRD 
GOLD.24 Again, to the best of our knowledge, no changes 
in cardiovascular disease coding in HES have been 
published previously. A systematic review of discharge 
coding accuracy reported improved accuracy over time.31 
A validation study comparing coronary heart disease in 
HES (ICD-10 codes I20- I25) to data from the prospective 
UK Whitehall II cohort study32 found a generally good 
agreement between the two data sources,33 suggesting 
reasonable recording quality in HES. An earlier study 
comparing data from HES and the Million Women Study34 
came to a similar conclusion.35 However, these studies 
only included data up to 2013 and 2005, respectively, and 
did not compare data from different time periods. Other 
studies based on local audits or comparison to specific 
disease registries36 have reported a notable underre-
porting of myocardial infarction cases in HES.21 37 Any 
increases or decreases in the observed number of cardio-
vascular diseases could thus be due to improvements or 
deteriorations in coding. The gradual change in distribu-
tions observed until 2008 agreed with the trends observed 
in CPRD GOLD and could relate to substitution of vague 
codes with more specific codes, better diagnostics (eg, 
wider availability of CT scans) or a slow shift in the char-
acteristics of the underlying patient populations. The first 
major change occurred in March 2010, following a new 
version of NHS Digital/HSCIC Coding Clinic Guidance in 
February.38 This guideline included provisions for stricter 
coding of I21 Acute Myocardial Infarction, requiring a 
different coding of myocardial infarction in subsequent 
trusts to avoid overcounting. The additional changes in 
2012 and 2014 both happened in April, coinciding with 
the financial year of the National Health Service and the 
publishing of updates to the National Clinical Coding 
standards,39 making it likely that they too are the result 
of changes in coding practice. As these changes mostly 
occurred within the group I20–I25, they might not affect 
studies that use all of these codes, but may lead to prob-
lems if authors include only a single code from this group 
(eg, I21). Related preliminary results on hospital admis-
sions for all ICD-10 codes (not only chapter I) using a 
traditional interrupted time series analysis showed 
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Table 1 Variability in CPRD GOLD and HES and their potential causes and solutions
Finding Observable cause Possible original cause Possible solutions
CPRD GOLD
Gradual change in the population 
distribution between 2001 and 
2007
Increases in the prevalence of 
recorded cardiovascular disease
Demographic changes 
(eg, ageing); incremental 
improvements in diagnostic 
coding or in clinical procedures
Incremental learning of 
models; inclusion of time 
interaction effect
Shift in the direction of change 
in 2008
After the previous year’s increase, 
the prevalence of CHD, heart failure 
and PAD started decreasing again 
around the same time
No immediate reason identified Separate analyses of 
prechange and postchange 
data
Oscillations in the data 
distributions after 2010
Changes in the distribution of 
socioeconomic status in the target 
distribution
Selective dropout of practices, 
possibly related to a switch 
in the practice management 
software
Mixed models with practice 
effects
HES
Gradual change in the population 
distribution between 2001 and 
2008
Increase in reported chronic CHD 
and atrial fibrillation; decreases in 
reported angina pectoris, acute 
myocardial infarction, heart failure 
and stroke
Demographic changes 
(eg, ageing); incremental 
improvements in diagnostic 
coding or in clinical 
procedures; selective increase 
of disease incidence
Incremental learning 
of models; inclusion of 
continuous time interaction 
effect
Shift in the direction of change 
in 2009
Increased coding of transient 
cerebral ischaemic attacks between 
2009 and 2010
No immediate reason identified Separate analyses of 
prechange and postchange 
data
Abrupt change in March 2010 Drop in acute myocardial infarction 
coding
Update to the HSCIC Coding 
Clinic Guidance in February 
2010
Separate analyses; 
incremental learning of 
models
Further abrupt changes in April 
2012 and 2014
Sudden increase in acute 
myocardial infarction coding in 
2012 with concomitant drop in 
subsequent myocardial infarction 
records; sudden further decrease in 
angina pectoris codes in 2014
Update to the National Clinical 
Coding Guidance National 
Clinical Coding Standards 
ICD-10 fourth Edition
Separate analyses; 
incremental learning of 
models
CHD, coronary heart disease; CPRD GOLD, Clinical Practice Research Datalink; HES, Hospital Episode Statistics; ICD-10, International 
Classification of Diseases 10th revision; PAD, peripheral arterial disease.
further, similar changes in non- cardiovascular chapters; 
these results will be disseminated in a further study evalu-
ating life- style related diseases.
It is challenging to disentangle changes solely due to 
how diseases are recorded from other, genuine shifts in 
the patient population. While abrupt changes like the 
one observed here for myocardial infarction strongly 
suggest an exogenous cause such as new clinical coding 
guidelines, continuous, gradual changes over a long 
time period can be more difficult to classify. However, 
we believe that it is important that researchers are aware 
of potential variations irrespective of the cause. Even in 
cases where changes are attributable to demographic 
shifts, accounting for them in the statistical analysis might 
still be warranted. The impact of observed changes, 
genuine as well as artificial, always depends on the 
specific research question.40 For example, an increase in 
the estimated population prevalence of heart failure from 
0.7% to 1.0% might not impact findings when accounting 
for heart failure as a covariate in a larger cohort, but 
might significantly alter the patient characteristics in a 
smaller, heart failure- only cohort. Similarly, while coding 
changes may greatly affect studies of incidence overtime, 
they might not change the results of a study looking at 
the effect of a risk factor on an outcome unless coding 
changes are biased towards certain patient populations. 
Insights gained from temporal variability analysis can be 
used to investigate and account for changes in patient 
cohorts across years.
Although some of the findings presented in this study 
could be detected with conventional methods such as 
traditional time series analysis of incidence rates, these 
methods usually require a formal definition of the time 
point at which changes happen. They further do not 
handle multivariate, multitype and multimodal data well17 
and require a separate analysis for each variable. This is 
particularly problematic when analysing changes in multi-
nomial variables such as ICD-10 codes. More traditional 
methods might further struggle with large sample sizes, 
whereas the structure of the variability metrics allows for 
a flexible modelling and subsequent hypothesis testing 
via statistical process control. Temporal variability metrics 
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together with the tools provided in our EHRtemporalVari-
ability R package facilitate the calculus from raw data 
tables directly to visualisation. Results can be shared on 
the Shiny user interface (http:// ehrt empo ralv aria bility. 
upv. es), aiding transparency and communication.
limitations
Results in this study are limited by the fact that the condi-
tions chosen for inclusion represented a convenience 
sample based on the overlap between the two projects for 
which the data was originally obtained. The results shown 
here therefore do not constitute a systematic, in- depth 
validation study of cardiovascular disease recording. 
Indeed, the aim of this study was not to comprehensively 
investigate the data quality of cardiovascular coding in 
CPRD GOLD and HES but to show how systematic, data- 
driven methods for studying temporal variability can help 
to identify potential coding inconsistencies over time early 
on in a project and allow researchers to a priori adjust the 
analysis accordingly. We believe that routine checks of the 
temporal variability of study data will aid the validity and 
reproducibility of medical and epidemiological studies. 
Reporting coding variability in online supplementary 
material can help readers judge the reliability of codelists 
and strengthen the conclusions. The analysis presented 
here was also limited to a manual inspection of the plots, 
as would be appropriate for interactive data quality anal-
ysis at the start of a project. The framework can easily be 
extended to allow for a more formal statistical process 
control (see Sáez et al (2015 and 2018)17 19 for guidance). 
Finally, changes in both databases were analysed in isola-
tion. It is possible that the impact of some changes is miti-
gated if records from both databases are used jointly to 
define the presence or absence of disease.21
Despite the promising results, we must note that vari-
ability metrics are solely based on recorded data and will 
not detect the same data quality issues and trends iden-
tified by other, dedicated validation studies based on 
manual code review or GP questionnaires.7 They are not 
meant to replace in- depth validation of data sources but 
rather complement them. Extensive validation studies 
are costly and are dependent on the exact codelists used 
during validation. Our data- driven approach might be 
well suited as a first step to signal the need for an exten-
sive validation. With regard to the findings in this study, a 
reasonable first step in assessing their impact for a specific 
research study might be to perform analysis stratified 
by NHS financial year or observed stable periods. How 
results should be reported and whether the data are fit for 
purpose then depends on the results of these sensitivity 
analyses and the exact research questions investigated.
COnClusIOn
We identified previously unreported variability in the 
frequency of cardiovascular codes in CPRD GOLD and 
HES between 2001 and 2015 using temporal variability 
measures that require minimal prior specification. In 
doing so, we have demonstrated the utility of application 
of data- driven approaches to data quality on two of the 
most important data resources for clinical research in the 
UK. We demonstrated that the methods can be imple-
mented in an unsupervised, scalable manner, providing 
non- parametric visualisations of data recording trajecto-
ries to measure their variability. The results from this vari-
ability analysis enable researchers to adjust their analysis 
and ensure reproducible results.
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